Testing inhomogeneous solvation theory in structure-based ligand discovery

被引:56
|
作者
Balius, Trent E. [1 ]
Fischer, Marcus [1 ,7 ,8 ]
Stein, Reed M. [2 ]
Adler, Thomas B. [1 ]
Nguyen, Crystal N. [3 ]
Cruz, Anthony [4 ,5 ]
Gilson, Michael K. [3 ]
Kurtzman, Tom [4 ,5 ,6 ]
Shoichet, Brian K. [1 ]
机构
[1] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA
[2] Univ Calif San Francisco, Grad Program Pharmaceut Sci & Pharmacogen, San Francisco, CA 94158 USA
[3] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA
[4] Lehman Coll, Dept Chem, Bronx, NY 10468 USA
[5] CUNY, Grad Ctr, PhD Program Chem, New York, NY 10016 USA
[6] CUNY, Grad Ctr, PhD Program Biochem, New York, NY 10016 USA
[7] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA
[8] St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA
基金
美国国家卫生研究院;
关键词
water; inhomogeneous solvation theory; ligand discovery; structure-based drug design; docking; MOLECULAR-DYNAMICS; FREE-ENERGIES; ACTIVE-SITE; WATER-MOLECULES; THERMODYNAMIC CONTRIBUTIONS; FLUID APPROACH; BINDING-SITE; SOLVENT; DOCKING; FLEXIBILITY;
D O I
10.1073/pnas.1703287114
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Binding-site water is often displaced upon ligand recognition, but is commonly neglected in structure-based ligand discovery. Inhomogeneous solvation theory (IST) has become popular for treating this effect, but it has not been tested in controlled experiments at atomic resolution. To do so, we turned to a grid-based version of this method, GIST, readily implemented in molecular docking. Whereas the term only improves docking modestly in retrospective ligand enrichment, it could be added without disrupting performance. We thus turned to prospective docking of large libraries to investigate GIST's impact on ligand discovery, geometry, and water structure in a model cavity site well-suited to exploring these terms. Although top-ranked docked molecules with and without the GIST term often overlapped, many ligands were meaningfully prioritized or deprioritized; some of these were selected for testing. Experimentally, 13/14 molecules prioritized by GIST did bind, whereas none of the molecules that it deprioritized were observed to bind. Nine crystal complexeswere determined. In six, the ligand geometry corresponded to that predicted by GIST, for one of these the pose without the GIST term was wrong, and three crystallographic poses differed fromboth predictions. Notably, in one structure, an ordered water molecule with a high GIST displacement penalty was observed to stay in place. Inclusion of this water-displacement term can substantially improve the hit rates and ligand geometries from docking screens, although the magnitude of its effects can be small and its impact in drug binding sites merits further controlled studies.
引用
收藏
页码:E6839 / E6846
页数:8
相关论文
共 50 条
  • [1] Structure-based ligand discovery for nutrient transporters
    Schlessinger, Avner
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [2] Structure-based ligand discovery for nutrient transporters
    Schlessinger, Avner
    FASEB JOURNAL, 2016, 30
  • [3] Structure-Based Ligand Discovery for Solute Carrier Transporters
    Schlessinger, Avner
    BIOPHYSICAL JOURNAL, 2013, 104 (02) : 199A - 199A
  • [4] Structure-based discovery of a new affinity ligand to pancreatic α-amylase
    Westerfors, M
    Tedebark, U
    Andersson, HO
    Öhrman, S
    Choudhury, D
    Ersoy, O
    Shinohara, Y
    Axén, A
    Carredano, E
    Baumann, H
    JOURNAL OF MOLECULAR RECOGNITION, 2003, 16 (06) : 396 - 405
  • [5] Ligand docking and virtual screening in structure-based drug discovery
    Cavasotto, Claudio N.
    FROM PHYSICS TO BIOLOGY: THE INTERFACE BETWEEN EXPERIMENT AND COMPUTATION, 2006, 851 : 34 - 49
  • [6] Ligand docking and structure-based virtual screening in drug discovery
    Cavasotto, Claudio N.
    Orry, Andrew J. W.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (10) : 1006 - 1014
  • [7] CINF 60-Ligand-based drug discovery in an era of structure-based drug discovery
    Martin, Yvonne C.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [8] Muscarinic Receptors as Model Targets and Antitargets for Structure-Based Ligand Discovery
    Kruse, Andrew C.
    Weiss, Dahlia R.
    Rossi, Mario
    Hu, Jianxin
    Hu, Kelly
    Eitel, Katrin
    Gmeiner, Peter
    Wess, Juergen
    Kobilka, Brian K.
    Shoichet, Brian K.
    MOLECULAR PHARMACOLOGY, 2013, 84 (04) : 528 - 540
  • [9] Structure-based Ligand Design and the Promise Held for Antiprotozoan Drug Discovery
    Hunter, William N.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (18) : 11749 - 11753
  • [10] The role of structure-based ligand design and molecular modelling in drug discovery
    Tollenaere, JP
    PHARMACY WORLD & SCIENCE, 1996, 18 (02): : 56 - 62